138030-50-9 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
ETHYL 1-(3-PYRIDYLMETHYL)PIPERIDINE-4-CARBOXYLATE is used as a research compound for its potential therapeutic properties, particularly in the development of treatments for neurological disorders.
Used in Central Nervous System Stimulation:
ETHYL 1-(3-PYRIDYLMETHYL)PIPERIDINE-4-CARBOXYLATE is used as a stimulant for the central nervous system, which may have implications for the treatment of certain neurological conditions.
Used in the Treatment of Neurological Disorders:
In the field of neurology, ETHYL 1-(3-PYRIDYLMETHYL)PIPERIDINE-4-CARBOXYLATE is used as a potential treatment for disorders such as Parkinson's disease and Alzheimer's disease, due to its possible effects on neurological function.
Safety Considerations:
While ETHYL 1-(3-PYRIDYLMETHYL)PIPERIDINE-4-CARBOXYLATE holds promise for medical applications, it is also recognized that it can be hazardous if not handled and used properly. Therefore, it is crucial to follow strict safety protocols during its use to mitigate any potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 138030-50-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,0,3 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 138030-50:
(8*1)+(7*3)+(6*8)+(5*0)+(4*3)+(3*0)+(2*5)+(1*0)=99
99 % 10 = 9
So 138030-50-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O2/c1-2-18-14(17)13-5-8-16(9-6-13)11-12-4-3-7-15-10-12/h3-4,7,10,13H,2,5-6,8-9,11H2,1H3
138030-50-9Relevant academic research and scientific papers
Direct Reductive Amination of Carbonyl Compounds with H2 Using Heterogeneous Catalysts in Continuous Flow as an Alternative to N-Alkylation with Alkyl Halides
Laroche, Benjamin,Ishitani, Haruro,Kobayashi, Shū
supporting information, p. 4699 - 4704 (2018/12/04)
A general continuous-flow procedure for direct reductive amination of secondary and primary amines with aromatic and aliphatic aldehydes as well as ketones is reported. The use of hydrogen gas and commercially available Pt/C as a heterogeneous catalyst is a key. In addition to exhibiting an excellent functional group tolerance, this method allows the fast formation of C?N bonds without production of any hazardous chemical waste. Applications to the synthesis of key intermediates toward active pharmaceutical ingredients (Donepezil and Arformoterol/Tamsulosin) are also described. (Figure presented.).
Reductive amination of piperidines with aldehydes using borane-pyridine
Moormann
, p. 789 - 795 (2007/10/02)
Borane-pyridine complex (BAP) was found to be an excellent replacement for NaCNBH3 in the Borch reduction. Assorted aromatic, heterocyclic and aliphatic aldehydes were reacted with various substituted piperidines using standardized conditions.
